Cancer Charity Support Funds - Cancer Charity Support Fund Moderate

So that fewer people get cancer and more people survive cancer. This is the credo of the Cancer Charity Support Fund, which offers investors the opportunity to donate and invest in a single transaction. The donation is made by donating 50% of the yield to the non-profit institution Krebsforschung Schweiz for their services in the fight against cancer, in particular cancer research. Also of interest to investors are the tax advantages of a reduced wealth tax and the tax deductibility of the yield waiver.

The CCSF Moderate invests as broadly as possible across all asset classes. The equity component is invested in companies with a sustainable business policy and in companies active in the fight against cancer. These future-oriented investments promise attractive long-term returns and at the same time support the goals and values of the initiator Krebsforschung Schweiz in an innovative way.

The main investment objective of this sub-fund is to achieve appropriate long-term returns and capital gains in the accounting unit by investing in the asset classes listed below. The investment focus is determined on a situational basis. The investments may each focus on a few asset classes. In the case of investments in equities, the focus is on companies that are active in cancer research and the fight against cancer and/or have a sustainable business activity.

As an investor in the Cancer Charity Support Fund Moderate, you also benefit from tax deductions. More information and the tax form can be found on the website of the Charity Support Fund Moderate. The Charity Support Fund Moderate is geared towards capital gains as well as capital gains, has an investment horizon of at least five years and, due to its risk tolerance, is willing and able to temporarily absorb losses. The risk of loss is limited. The sub-fund is not suitable for investors who are looking for a speculative investment or who want or need the invested capital in the short term.

Tax form on on the website of the Charity Support Fund Moderate
NAV/unit
CHF
YTD

Lowest/Highest NAV
/
/
NAV
CHF
in millions
Fund management / Fund administrator
PMG Investment Solutions AG
Custodian
Reichmuth & Co Privatbankiers
Investment Manager
PMG Investment Solutions AG
Auditor
BDO AG
Supervisory authority
FINMA
Domicile
Switzerland
Fiscal year end
31. December
Launch date
July 31st 2009
Valuation frequency
monthly
Distribution policy
accumulating
Publication medium
www.swissfunddata.ch, www.pmg.swiss
ISIN
CH0102924906
Valor
10292490
Bloomberg
CCSFMOD SW
Subscription category
shares and amount
Minimal initial subscription
1
Reference currency
CHF
Cut-off time for subscription
14:30
Distribution in Switzerland
yes
Distribution in Germany
no
Subscription fee maximum
none
Redemption fee maximum
none
TER excluding performance fee
3.12%
TER including performance fee
3.12%
TER date
December 31st 2021
Management fee applied
1.50%
German tax category
intransparent
Presentation
Fund prospectus
KIID
Annual report
Semi-annual report
Factsheets
Management commentary
German Investor Fund Tax Information

Description

So that fewer people get cancer and more people survive cancer. This is the credo of the Cancer Charity Support Fund, which offers investors the opportunity to donate and invest in a single transaction. The donation is made by donating 50% of the yield to the non-profit institution Krebsforschung Schweiz for their services in the fight against cancer, in particular cancer research. Also of interest to investors are the tax advantages of a reduced wealth tax and the tax deductibility of the yield waiver.

The CCSF Moderate invests as broadly as possible across all asset classes. The equity component is invested in companies with a sustainable business policy and in companies active in the fight against cancer. These future-oriented investments promise attractive long-term returns and at the same time support the goals and values of the initiator Krebsforschung Schweiz in an innovative way.

The main investment objective of this sub-fund is to achieve appropriate long-term returns and capital gains in the accounting unit by investing in the asset classes listed below. The investment focus is determined on a situational basis. The investments may each focus on a few asset classes. In the case of investments in equities, the focus is on companies that are active in cancer research and the fight against cancer and/or have a sustainable business activity.

As an investor in the Cancer Charity Support Fund Moderate, you also benefit from tax deductions. More information and the tax form can be found on the website of the Charity Support Fund Moderate. The Charity Support Fund Moderate is geared towards capital gains as well as capital gains, has an investment horizon of at least five years and, due to its risk tolerance, is willing and able to temporarily absorb losses. The risk of loss is limited. The sub-fund is not suitable for investors who are looking for a speculative investment or who want or need the invested capital in the short term.

Tax form on on the website of the Charity Support Fund Moderate

Fund Characteristics

Fund management / Fund administrator
PMG Investment Solutions AG
Custodian
Reichmuth & Co Privatbankiers
Investment Manager
PMG Investment Solutions AG
Auditor
BDO AG
Supervisory authority
FINMA
Domicile
Switzerland
Fiscal year end
31. December
Launch date
July 31st 2009
Valuation frequency
monthly
Distribution policy
accumulating
Publication medium
www.swissfunddata.ch, www.pmg.swiss
ISIN
CH0102924906
Valor
10292490
Bloomberg
CCSFMOD SW
Subscription category
shares and amount
Minimal initial subscription
1
Reference currency
CHF
Cut-off time for subscription
14:30
Distribution in Switzerland
yes
Distribution in Germany
no
Subscription fee maximum
none
Redemption fee maximum
none
TER excluding performance fee
3.12%
TER including performance fee
3.12%
TER date
December 31st 2021
Management fee applied
1.50%
German tax category
intransparent

Documents

Presentation
Fund prospectus
KIID
Annual report
Semi-annual report
Factsheet
Management commentary
German Investor Fund Tax Information